UCSF
UCSF and MIT researchers have developed a way to edit the epigenome and then completely reverse the changes, when needed.
The 20-year study showed the test provided an accurate assessment of the risk of long-term metastases and mortality for patients with localized prostate cancer.Â
Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications. Â
Germline Genetic Variants May Influence Tumor Immune Microenvironment, Treatment Response
A new study lends credence to the idea that pre-existing anti-cancer immunity depends heavily on patients' genetic background, according to one of the researchers.
Lung Cancer Metastasis Study Relies on CRISPR-Based Method to Track Single-Cell Lineages
Researchers traced the development of thousands of engineered human lung cancer cells within a mouse model of disease to examine metastasis.